SCHEMBL14844238

SCHEMBL14844238

O=C(O)C1CCCCC1c1onc2c1CCCC2

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.38
TP53 P04637 6/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
FABP4 P15090 8/20 0.35
FABP5 Q01469 8/20 0.35
THRB P10828 1/20 0.34
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
PKM P14618 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2595283 0.83 SMN1; SMN2 (0.40) SMN1; SMN2TP53L3MBTL1POLBFABP4
SCHEMBL2596227 0.83 SMN1; SMN2 (0.35) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL15914064 0.75 SMN1; SMN2 (0.39) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL14853198 0.75 SMN1; SMN2 (0.39) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL3590392 0.65 SMN1; SMN2 (0.50) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL2579226 0.65 MAPT (0.39) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL2579228 0.65 MAPT (0.39) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL2586413 0.65 SMN1; SMN2 (0.40) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL2586411 0.65 SMN1; SMN2 (0.40) SMN1; SMN2TP53L3MBTL1KDM4EPOLB
SCHEMBL23846423 0.62 SMN1; SMN2 (0.50) SMN1; SMN2TP53L3MBTL1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2763997-A1 CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2014-08-13 EP disclosed
WO-2013050334-A1 CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES AS V1A ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2013-04-11 WO disclosed